| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |